Enrollment Begins for PRESTIGE LP Cervical Disc Trial

Medtronic announced the beginning of enrollment in the PRESTIGE LP Cervical Disc clinical trial, Medtronic's third major artificial cervical disc trial designed to explore new technologies for the treatment of degenerative back disease. This clinical trial will be used to help support an application to the FDA for future commercial sale of the device in the U.S.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=506070XSL_NEWSML_TO_NEWSML_WEB.xml)